Skip to content

Author

Mingjun Zhang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Clinical trial Open access Aug 2026

Safety and efficacy of first-line iparomlimab and tuvonralimab (QL1706) plus carboplatin and etoposide in patients with extensive-stage small cell lung cancer: an open-label, single-arm, phase 2 trial (DUBHE-L-209)

Background Iparomlimab and tuvonralimab (QL1706) is a MabPair product consisting of PD-1 and CTLA-4 monoclonal antibodies. This single-arm, multicenter, phase 2 study assessed the safety and efficacy of first-line QL1706 plus etoposide and carboplatin (EC) for extensive-stage small cell lung cancer (ES-SCLC). Methods P...

Yun Fan, Run-Xiang Yang, Xu-Hong Min et al. · 0 citations
Jul 2026

Molecular Concatenation of 3,5-Dichloro-2,6-Difluoropyridin-4-amine with Heterocyclic Carboxylic Acids and Evaluation of their Antifungal Activity.

A1 and A2 are identified as promising, bee-safe leads for next-generation SDHI fungicides based on a 3,5-dichloro-2,6-difluoropyridin-4-amine scaffold and disrupt mycelial morphology and inhibit SDH, supported by molecular docking and enzyme activity assays.

Bo-Yi Sun, Hui Wang, Dan-Dan Wang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.